Pharma R&D Spend Drops 3.6% as Pipeline Prioritizations Take Shape on March 26, 2026 clinical development cost reduction Dosage Forms Drug Development impairment charges pipeline prioritization restructuring spending therapeutic areas +
Rare Disease Vouchers Caught in Political Abyss: Recent Updates on Reauthorization Efforts on January 26, 2026 Beak Bipartisan Support Chance Act Congress reauthorization Infrequent Mikaela Naylon Give Kids a Pediatric Disorder Priority Review Voucher PRV spending United States Food and Drug Administration +
UK Proposes Raising Payment Scheme for Branded Medicines to Nearly 25% Amid Industry Pushback on October 10, 2025 Consultation drugmakers Industry Nance-Horan syndrome payment pharmaceutical rebates Pricing Response process spending statutory scheme UK +
Prothena Halts Drug and Plans Major Layoffs After Second Rare Disease Trial Failure on May 27, 2025 AL birtamimab business options drug failure layoffs Phase 3 Clinical Trials Primary amyloidosis Prothena spending +